Contrario Medical Receives FDA 510(k) Clearance for Cyperus

Contrario Medical, Inc. announced that it received FDA 510(k) clearance for its Cyperus sperm separation device, according to PR Newswire. The announcement identifies Contrario Medical as a Houston-based medical device company developing next-generation sperm separation technology.

FDA 510(k) clearance announced

PR Newswire reported that the clearance applies to Contrario Medical’s Cyperus sperm separation device. The announcement centers on the FDA 510(k) clearance and the company’s work in sperm separation technology.

Contrario Medical described the development as an update involving its Cyperus device. PR Newswire’s summary identifies the company’s location and technology focus, while reporting the FDA clearance as the announced event.

The available report does not provide further details on the device’s clinical use, commercial availability, distribution activity, customer adoption, or timeline. Those topics should be distinguished from the reported regulatory clearance.

Points for medical device sales professionals

For medical device sales professionals tracking reproductive-health technology, the announcement adds a regulatory update involving Contrario Medical and the Cyperus sperm separation device. PR Newswire’s report connects the company with next-generation sperm separation technology.

The event is specifically an FDA 510(k) clearance announcement. It does not, based on the supplied report, establish claims about product uptake, market presence, clinical outcomes, account activity, or product positioning.

Sales professionals monitoring device developments can use the announcement as a defined reference point: Contrario Medical announced FDA 510(k) clearance for Cyperus, and PR Newswire characterized the company as Houston-based and focused on sperm separation technology.

Reported details

• Contrario Medical, Inc. announced FDA 510(k) clearance.
• The named device is the Cyperus sperm separation device.
• PR Newswire described Contrario Medical as a Houston-based medical device company.
• PR Newswire said the company is developing next-generation sperm separation technology.

The announcement provides a regulatory milestone for stakeholders following sperm separation technology and reproductive-health device developments. Additional information would be needed to evaluate activity beyond the FDA 510(k) clearance reported by PR Newswire.